Cargando…
Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398024/ https://www.ncbi.nlm.nih.gov/pubmed/29694283 http://dx.doi.org/10.18553/jmcp.2018.24.5.487 |
_version_ | 1785084001118060544 |
---|---|
author | Orlowski, Robert Z. |
author_facet | Orlowski, Robert Z. |
author_sort | Orlowski, Robert Z. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10398024 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Academy of Managed Care Pharmacy |
record_format | MEDLINE/PubMed |
spelling | pubmed-103980242023-08-04 Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma Orlowski, Robert Z. J Manag Care Spec Pharm Letters Academy of Managed Care Pharmacy 2018-05 /pmc/articles/PMC10398024/ /pubmed/29694283 http://dx.doi.org/10.18553/jmcp.2018.24.5.487 Text en Copyright © 2018, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Letters Orlowski, Robert Z. Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma |
title | Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma |
title_full | Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma |
title_fullStr | Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma |
title_full_unstemmed | Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma |
title_short | Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma |
title_sort | letter--incorporating real-world evidence and patient value criteria into value-based frameworks for relapsed/refractory multiple myeloma |
topic | Letters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398024/ https://www.ncbi.nlm.nih.gov/pubmed/29694283 http://dx.doi.org/10.18553/jmcp.2018.24.5.487 |
work_keys_str_mv | AT orlowskirobertz letterincorporatingrealworldevidenceandpatientvaluecriteriaintovaluebasedframeworksforrelapsedrefractorymultiplemyeloma |